NCT02034435View on ClinicalTrials.gov

Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Metabolic Syndrome
Interventions
OTHER

Low Salt diet plus Placebo tablet

OTHER

Low Sodium diet plus Salt tablet

DRUG

Epleronone

50mg daily

DRUG

Amlodipine

5mg daily

Trial Locations (1)

37232-6602

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University Medical Center

OTHER

NCT02034435 - Endogenous Renin-Angiotensin-Aldosterone System and Glucose Metabolism | Biotech Hunter | Biotech Hunter